StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Integra LifeSciences's ebitda for the twelve months ending Jun 30, 2020 was $170.98M, down 30.7% year over year. For fiscal 2019 it was $203.22M, down 8.3% from the year before. Over ten years it grew 4.0% a year on average. The highest annual figure on record is $221.73M in fiscal 2018.

Annual ebitda

PeriodPeriod endValueChange
FY2019Dec 31, 2019$203.22M-8.3%
FY2018Dec 31, 2018$221.73M+65.8%
FY2017Dec 31, 2017$133.75M-28.9%
FY2016Dec 31, 2016$188.01M+35.8%
FY2015Dec 31, 2015$138.45M+21.1%
FY2014Dec 31, 2014$114.29M+72.2%
FY2013Dec 31, 2013$66.39M-47.5%
FY2012Dec 31, 2012$126.39M+20.3%
FY2011Dec 31, 2011$105.08M-23.8%
FY2010Dec 31, 2010$137.87M+0.3%
FY2009Dec 31, 2009$137.51M+76.0%
FY2008Dec 31, 2008$78.13M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2020Jun 30, 2020$43.76M-39.9%
Q1 FY2020Mar 31, 2020$56.25M-5.3%
Q4 FY2019Dec 31, 2019$63.96M+3.5%
Q3 FY2019Sep 30, 2019$7.01M-86.7%
Q2 FY2019Jun 30, 2019$72.85M+33.6%
Q1 FY2019Mar 31, 2019$59.40M+12.8%
Q4 FY2018Dec 31, 2018$61.79M+82.4%
Q3 FY2018Sep 30, 2018$52.73M+66.8%
Q2 FY2018Jun 30, 2018$54.54M+41.4%
Q1 FY2018Mar 31, 2018$52.68M+77.5%
Q4 FY2017Dec 31, 2017$33.88M-42.7%
Q3 FY2017Sep 30, 2017$31.61M–
Q2 FY2017Jun 30, 2017$38.58M–
Q1 FY2017Mar 31, 2017$29.68M–
Q4 FY2016Dec 31, 2016$59.08M–

More Integra LifeSciences figures

See a number that looks wrong?